SMi is proud to present its 9th Annual conference on Adaptive Designs in Clinical Trials taking place on the 3rd - 4th April in London.
Since the recent advances and successes in adaptive platform clinical trials, there has been a rejuvenated interest into adaptive designed approaches. Adaptive designed approaches to clinical trials is an exciting area of biometric and statistics for recent statistical and computational advances, and changes to regulatory frameworks, have enabled more complex, robust and flexible clinical trials not previously offered by traditional clinical trial design.

This conference will highlight multiple topics within adaptive design encompassing the new approaches and trends amongst research and the industry. Topics will include the successes, strengths and pitfalls of key trends within drug development such as Bayesian Strategies, Seamless approaches, Dose-finding studies, and adaptive development programmes. It will also discuss pioneering research and industry-led case studies of adaptive designed clinical trials within key therapy areas, such as oncology, and the real life clinical and statistical adaptations these trials have led to.

Attend this conference to:

  • Learn about new adaptive design strategies to clinical trials, their strengths, pitfalls and future implications
  • Recognise current trends in adaptive design in clinical and platform trials
  • Understand how adaptive design approaches can offer flexibility and power to clinical trials.
  • Understand how to use adaptive design to maximize trial cost effectiveness and reduce attrition
  • Gain an insight into new adaptive design strategies from real-life case studies in key therapy areas like Oncology
  • Hear about regulatory updates direct from regulatory bodies, and understand how can to learn from these


Clinical trial managers & associates
Directors of business developement
Data managers
Senior statisticians
Professors of statistics
Directors of Clinical trials
Medical doctors
PhD students
Clinical scientists

Accovion; Actelion Pharmaceuticals Ltd; Affibody; AstraZeneca; Bayer HealthCare; Bays Consulting; Berry Consultants, LLP; Bio Med Central; Boehringer-Ingelheim; Cancer Research UK; Cmed CRS Ltd; Cornell University; Daiichi Sankyo; DEBIOPHARM INTERNATIONAL SA; EMD Serono, Inc; Enterome; European Medicines Agency; European Medicines Agency (EMA); GW Pharmaceuticals; H. Lundbeck A/S; Highbury Regulatory Science; hVIVO Services Ltd; ICON Clinical Research; INSERM; Johnson & Johnson; king abdullah international medical research center ; MHRA; Orion Pharma; Pfizer Global Pharmaceuticals; Queen Mary, University of London; Rottapharm Biotech S.r.l.; Sandoz Biopharmaceuticals; Sanofi Aventis; Sanofi Pharma; Sigmaclinical; Synthon BV; The Cure Parkinsons Trust; UCL Cancer Institute; University Of Bath; University of Calgary; University of Pisa; Voisin Consulting Life Sciences; Warwick Medical School ;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Alex Sverdlov

Alex Sverdlov, Director, Statistical Scientist, Novartis

9:10 Adaptive multi-arm randomisation approaches and methodology to clinical trials

Alex Sverdlov

Alex Sverdlov, Director, Statistical Scientist, Novartis

  • Methodology for applying randomisation approaches to clinical trials
  • Applying multi-arm randomisation to drug development
  • Examples of randomisation application and methodology
  • 9:50 Hot topics and case studies in adaptive designs from a company’s perspective

    Frank Fleischer

    Frank Fleischer, Principal Methodology Statistician, Boehringer Ingelheim Pharma GmbH & Co. KG

  • Towards an adaptive platform based approach in oncology dose finding
  • Statistical Go / NoGos and alternative development pathways
  • Adaptive designs in the biosimilar framework
  • Case studies
  • 10:30 Morning Coffee & Networking Break

    11:00 Adaptive aspects in clinical development in Grünenthal

    Cecile Dubois

    Cecile Dubois, Head Biostatistics, Grunenthal Gmbh

  • Single trials with adaptive design vs adaptive nature of clinical development programs
  • Adaptive trial design aspects specific to indication pain/drug class opioids
  • Case studies of trials with adaptive designs in GRT
  • 11:40 Adaptive design: Historical perspective of how it arose

    John Warren

    John Warren, Director, Medicines Assessment Ltd

  • What was the old system?
  • Why was it insufficient?
  • What happens next?
  • 12:20 Networking Lunch

    13:30 Bayesian adaptive design in device development

    Giacomo Mordenti

    Giacomo Mordenti, Global Biometrics Director, Livanova

  • The adaptive design of device clinical trials
  • Operational and logistical pitfalls common in device development
  • Important differences to consider between adaptive device and drug development
  • Case studies of Bayesian statistics in practise in devices
  • 14:10 Adaptive clinical development: From patent to market

    Michael Davies

    Michael Davies, Co-Founder & Chief Medical Officer, Blueberry Therapeutics Ltd.

  • Adaptive clinical designs can speed development and cut costs
  • Upfront effort is required
  • Talk to the regulators about your ideas
  • 14:50 Afternoon Tea & Networking

    15:20 The integration of adaptive designs into neuroscience drug development

    Richard Wyse

    Richard Wyse, Director of Research and Development, The Cure Parkinsons Trust

  • Relevant new clinical developments in Parkinson’s disease
  • Major impact of disease-modifying therapeutics
  • Overcoming challenges
  • Developing innovative new strategies for testing drug combinations
  • 16:00 Testing a secondary endpoint after a group sequential test

    Christopher Jennison

    Christopher Jennison, Professor of Statistics, University Of Bath

  • Inference after a group sequential test needs care
  • Some plausible looking methods are not actually valid
  • We describe a general framework for multiple testing in the group sequential setting
  • We discuss testing a secondary hypothesis after stopping to reject the primary null hypothesis
  • 16:40 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    James Matcham

    James Matcham, Head of Biometrics, Early Clinical Development, AstraZeneca

    9:10 Building an adaptive design capability in early development

    James Matcham

    James Matcham, Head of Biometrics, Early Clinical Development, AstraZeneca

    Describing the journey at AstraZeneca
    Building skills and confidence in designing adaptive clinical trials
    Implications for early phase decision making

    9:50 Adaptive designs: How preclinical, translational and big data can contribute to a better design

    Emmanuel Pham

    Emmanuel Pham, VP Biometrics, Ipsen

  • Adaptive design often require a model underlying hypotheses
  • Developing these model is not easy when lacking of internal clinical data
  • Preclinical (non-clinical) data can be very useful, but often require to use translational expertise to be used efficiently
  • Big Data is also an incredible source of knowledge, but requires also a careful management to be integrated in a model
  • 10:30 Morning Coffee & Networking Break

    11:00 Bayesian adaptive trials for medical device and pharmaceutical trials

    Tom Parke

    Tom Parke, Director of Software Solutions, Berry Consultants, LLP

  • The design, modelling and simulation of bayesian methods in drug and device clinical trials
  • Platform / Master protocol designs
  • Case studies of bayesian statistics in practise – the EPAD trial
  • Innovative adaptive design to address immediate threats – Ebola trial 2015
  • 11:40 Adaptive design to check the dose range of a dose-ranging study

    Simon Kirby

    Simon Kirby, Senior Director, Pfizer

    Studies of adaptive dose-ranging designs have not necessarily found advantages for adaptive designs however adaptive designs may have a role to play in checking that the dose range

  • The 3 parameter Emax model and empirical justification for focusing on this model
  • Adaptations to try to ensure that the dose range goes low enough and high enough
  • Simulation study
  • Results of simulation study
  • Conclusions
  • 12:20 Networking Lunch

    13:30 Enrichment designs in oncology

    Loic Darchy

    Loic Darchy, Head of Statistical Methodology Group, Sanofi R&D

  • Overview of enrichment designs in statistical literature
  • Opportunities and challenges of enrichment design in oncology target therapies and development
  • Case Studies for adaptive enrichment
  • 14:10 Adaptive dose finding designs in oncology early phase trials: An industry experience

    Bo Huang

    Bo Huang, Director of Biostatistics, Pfizer Inc.

  • Overview of adaptive early dose-finding studies
  • A time-to-event continual reassessment method with adaptive weight function incorporating cyclical data
  • The practical implications of adaptive design on Pfizer oncology drug development with two case studies
  • 14:50 Afternoon Tea & Networking

    15:20 ICH E9(R1) and adaptive designs

    Christine Fletcher

    Christine Fletcher, Executive Director Biostatistics, Amgen Ltd

  • Introduce the new estimand and sensitivity analysis framework
  • Consider if the new framework will impact the design, conduct, analysis and reporting of adaptive trials
  • Discuss whether any new unique challenges will be introduced by the framework
  • 16:00 Biomarker-driven drug development in oncology

    16:40 Chairman’s Closing Remarks and Close of Day Two


    Official Media Partner

    Official Publication



    Writing Clinical Trial Simulators

    Writing Clinical Trial Simulators

    Copthorne Tara Hotel
    5th April 2017
    London, United Kingdom


    Copthorne Tara Hotel

    Scarsdale Place, Kensington, London, United Kingdom

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.



    Media Partners

    Cutting Edge

    Official Media Partner

    Cutting Edge Information provides customized research and benchmarking reports to pharmaceutical, biotechnology and other life science companies. We provide off-the-shelf and customized research for key areas including medical affairs, clinical development, market access, regulatory affairs, marketing management, sales and HCP fair market value.

    Media Partners

    International Journal of Functional Informatics and Personalised Medicine

    Official Publication

    Functional informatics and personalised medicine in the new era of biomedical sciences and computational sciences are interactive disciplines that hold great promise for the advancement of cutting-edge research and development in biomedical informatics and pharmaceutical sciences. IJFIPM is dedicated to promoting the research, education and awareness of functional informatics and personalised medicine, and provides a common platform for the cross-fertilisation of ideas by bridging important and complementary disciplines into an interactive and attractive forum.

    International Journal of Computational Biology and Drug Design

    Official Publication

    IJCBDD, an International Society of Intelligent Biological Medicine official journal, bridges the gap between two very important, complementary disciplines, computational biology and drug design. Through advances in high-throughput genome sequencing and digital imaging technologies, biocomputing, drug design and medical research have unfolded new, predictive sciences such as genomics, proteomics, lipidomics, metabolomics, cytomics and pharmaconomics. These promote new computational, statistical and biomedical approaches to drug design/development, besides unleashing the potential of significantly more accurate, effective personalised diagnosis, therapeutics and patient care.

    International Journal of Bioinformatics Research and Applications

    Official Publication

    Bioinformatics is an interdisciplinary research field that combines biology, computer science, mathematics and statistics into a broad-based field that will have profound impacts on all fields of biology. The emphasis of IJBRA is on basic bioinformatics research methods, tool development, performance evaluation and their applications in biology. IJBRA addresses the most innovative developments, research issues and solutions in bioinformatics and computational biology and their applications.

    Int. J. of Biotechnology

    Official Publication

    IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.

    International Journal of Medical Engineering and Informatics

    Official Publication

    IJMEI promotes an understanding of the structural/functional aspects of disease mechanisms and the application of technology towards the treatment/management of such diseases. It seeks to promote interdisciplinary collaboration between those interested in the theoretical and clinical aspects of medicine and to foster the application of computers and mathematics to problems arising from medical sciences. IJMEI includes authoritative review papers, the reporting of original research, and evaluation reports of new/existing techniques and devices. Each issue also contains a comprehensive information service.

    International Journal of Biomedical Engineering and Technology

    Official Publication

    IJBET addresses cutting-edge research in the multi-disciplinary area of biomedical engineering and technology. Medical science incorporates scientific/technological advances combining to produce more accurate diagnoses, effective treatments with fewer side effects, and improved ability to prevent disease and provide superior-quality healthcare. A key field here is biomedical engineering/technology, offering a synthesis of physical, chemical, mathematical and computational sciences combined with engineering principles to enhance R&D in biology, medicine, behaviour, and health. IJBET includes the Asia-Pacific Chapter in Biomedical Wireless Technology (APC-BWT).

    Media Partners

    Medical News Today


    Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.

    Select Science


    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.



    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.



    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/

    Pharmaceutical Technology


    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.



    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.



    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.

    BioChem Adda


    BioChem Adda is a Not-just-for-Profit organization which aims to bring out the most reliable and transparent information about everything related to jobs, careers, education, news, articles, and events from the field of BioSciences and Chemistry!



    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.

    Technology Networks


    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com



    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!

    Inderscience Publishers


    Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.



    Drug Discovery Today


    Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
    Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.



    Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.



    Generics and Biosimilars Initiative (GaBI) was founded in 2008. GaBI aims to foster the worldwide efficient use of high quality and safe medicines at an affordable price, thus advancing and supporting the idea of accessible, affordable and sustainable health care. The objective of GaBI is to raise the scientific status of generic and biosimilar medicines, via well-documented and up-to-date information about generic and biosimilar medicines both in print (www.gabi-journal.net) and electronically (www.gabionline.net) in an open access format, providing high quality, scientifically sound and reliable information to healthcare professionals including physicians, pharmacists and nurses, consumers, drug developers, third-party payers, legislators and assessors; who are in need of a reliable, critical and independent source of information on all aspects of generic and biosimilar medicines. Subscribe to gain easy access of information on the latest scientific research and developments in generic and biosimilar medicines via GaBI Online to editorial@gabionline.net; or submit a manuscript to GaBI Journal to editorial@gabi-journal.net GaBI’s mission – Building trust in cost-effective treatments.



    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.

    Swiss Biotech Association


    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.



    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com



    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….

    evvnt Ltd


    evvnt enables people all over the world to fill their events utilising the most effective event listing sites on the web. Every minute, with little more than a click, more events and conferences appear in listings, in search engines and on mobile - discoverable by both category and location. With next to no effort customers of evvnt get better attendance, while consumers find events they previously had no idea existed. To date customers in 70 countries worldwide have submitted over 500,000 thousand event listings, created over 300,000 live links, and generated 1 million clicks to ticketing and registration pages. Learn more at www.evvnt.com


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Copthorne Tara Hotel

    Scarsdale Place
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.




    speaker image






    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.


    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.


    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.


    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title


    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event


    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71

    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.